Latest News for: dyne

Edit

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne

Hastings Tribune 17 Aug 2025
(“Dyne” or the “Company”) (NASDAQ.
Edit

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN

Nasdaq Globe Newswire 17 Aug 2025
(“Dyne” or the “Company”) (NASDAQ.
Edit

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN

PR Newswire 16 Aug 2025
16, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Dyne Therapeutics, Inc. ("Dyne" or the "Company") (NASDAQ ... On June 17, 2025, Dyne ...
Edit

INVESTOR ALERT: Pomerantz Law Firm Investigates ClaimsOn Behalf of Investors of Dyne Therapeutics, Inc. - DYN

Nasdaq Globe Newswire 05 Aug 2025
(“Dyne” or the “Company”) (NASDAQ.
Edit

INVESTOR ALERT: Pomerantz Law Firm Investigates ClaimsOn Behalf of Investors of Dyne

Hastings Tribune 05 Aug 2025
(“Dyne” or the “Company”) (NASDAQ.
Edit

Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-251 in Duchenne Muscular Dystrophy (DMD)

Nasdaq Globe Newswire 04 Aug 2025
- Data from the DELIVER registrational expansion cohort is expected in late 2025, with a potential BLA submission for U.S. accelerated approval anticipated in early 2026 - �� ... .
Edit

Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-251 in Duchenne

Enid News & Eagle 04 Aug 2025
- Data from the DELIVER registrational expansion cohort is expected in late 2025, with a potential BLA submission for U.S. accelerated approval anticipated in early 2026 - ... .
Edit

Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-251 in Duchenne Muscular Dystrophy (DMD) (Form 8-K) (Dyne Therapeutics Inc)

Public Technologies 04 Aug 2025
DYNE-251 in DMD • DYNE-251 has been granted Fast Track, Orphan Drug and Rare Pediatric disease designations by the FDA and Orphan Drug designation by the European Medicines Agency (EMA) for the treatment of DMD.
Edit

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. ...

Nasdaq Globe Newswire 01 Aug 2025
(“Dyne” or the “Company”) (NASDAQ.
Edit

Dyne Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights (Form 8-K) (Dyne Therapeutics Inc)

Public Technologies 28 Jul 2025
Dyne Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights. - Expected cash runway extended into Q3 2027, beyond multiple potential inflection points including Dyne's first planned commercial launch in early 2027 -.
Edit

Dyne Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Nasdaq Globe Newswire 28 Jul 2025
- Expected cash runway extended into Q3 2027, beyond multiple potential inflection points including Dyne’s first planned commercial launch in early 2027 - ... .
Edit

Quarterly Report for Quarter Ending June 30, 2025 (Form 10-Q) (Dyne Therapeutics Inc)

Public Technologies 28 Jul 2025
We expect our expenses to increase in connection with our ongoing activities, particularly as we advance the clinical development of DYNE-101 and DYNE-251, the development of our FSHD and Pompe programs and additional research programs.
Edit

Flags in Wisconsin to fly half-staff July 24 in honor of late Van Dyne firefighter Amie Sue Lee

Oshkosh Northwestern 23 Jul 2025
VAN DYNE – U.S ... Van Dyne Fire Department Safety Officer, Firefighter and Emergency Medical Responder Amie Sue Lee, 61, died suddenly July 14 at home in Black Wolf from complications of an injury she sustained in the line of duty July 1.
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Dyne Therapeutics Inc)

Public Technologies 18 Jul 2025
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) ... 0.5 ... 2 ... Dyne Therapeutics, Inc ... C/O DYNE THERAPEUTICS, INC., 1560 TRAPELO ROAD 3 ... C/O DYNE THERAPEUTICS, INC ... Dyne Therapeutics Inc.
Edit

Final Fantasy Doesn't Need Turn-Based Combat Back, It Needs Better Stories

Kotaku 11 Jul 2025
There’s been an undercurrent of opinion, ever since Clair Obscur ... Final Fantasy fans have been jealous ... CC. Share ... Email ... His encounter with Dyne, the friend whose life he accidentally ruined, is overshadowed by a cartoony infusion of clear-cut moralism.

Article Search

tools
×
×
×
×